Why Choose IvyGene™
The IvyGene™ Test: Non-Invasive Cancer Testing
Every day thousands of people in the USA alone are beginning to fight cancer. In 2016, more than 4,600 individuals in the U.S. were diagnosed with cancer daily. The first step to fighting cancer is identifying its presence early, which can be a difficult and frustrating process.
The IvyGene test is a blood test able to detect and measure DNA methylation patterns that are consistent with actual cancer presence. A highly accurate and sensitive test, the IvyGene test is a non-invasive tool to aid physicians in identifying cancer presence.
According to studies performed by the National Cancer Institute and American Cancer Society, individuals who identified 25 different types of cancer earlier had a greater chance of survival.
In combination with diagnostic tests, the IvyGene test is another step towards winning the battle with cancer.
Chances of Survival
How Does the IvyGene™ test Work?
The IvyGene test detects and measures DNA methylation patterns that are consistent with actual cancer presence. Methylation is a normal process, however cancer causes significant changes in gene expression, resulting in hypermethylation at specific target sites. The DNA from these sites is shed into the blood. The IvyGene test measures the methylation status of cell-free DNA extracted from blood samples and provides an IvyGene Score. An IvyGene Score of 19 and below is considered normal. An IvyGene Score of 20 or greater is considered elevated.
Uses of the IvyGene™ test:
IvyGene is intended to be used in conjunction with other diagnostic and confirmatory tests. It provides a non-invasive option to aid in the following:
- Confirm specific cancer presence
- Supplement other tests
- Follow-up to other diagnostics and screening tests. Such as abnormal imaging and BRCA1 and BRCA2
- Monitor for recurrence
How is this different from other DNA tests?
Many DNA tests identify the “propensity to have” or the “likelihood” that cancer will occur. The IvyGene test measures DNA methylation at specific target sites that indicates disease presence at the time of testing.